iRhythm Technologies to Present at the Canaccord Genuity 38th Annual Growth Conference


SAN FRANCISCO, July 26, 2018 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming Canaccord Genuity Growth Conference in Boston, MA.

iRhythm’s management is scheduled to present on Thursday, August 9, 2018 at 11:00am Eastern Time.  Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: www.irhythmtech.com.

About iRhythm Technologies, Inc. 
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Investor Relations Contact:
Lynn Pieper Lewis or Leigh Salvo
(415) 937-5404
investors@irhythmtech.com

Media Contact
Cherise Adkins 
(415) 486-3235
media@irhythmtech.com